Centessa Pharmaceuticals (CNTA)
15.45
0.61 (4.11%)
At close: Jan 15, 2025, 12:49 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -5.07 | -1.34 | -2.65 | -279.84 | -291.8 |
| PS Ratio | 111.71 | n/a | n/a | n/a | n/a |
| PB Ratio | 3.24 | 0.86 | 2.06 | -137.79 | n/a |
| P/FCF Ratio | -4.77 | -1.44 | -7.43 | -290.66 | -264.7 |
| P/OCF Ratio | -4.77 | -1.44 | -7.44 | -290.66 | -264.7 |
| OCF/S Ratio | -23.4 | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.36 | 0.21 | 0.15 | -0.25 | n/a |
| Quick Ratio | 8.00 | 11.05 | 24.88 | 1.18 | n/a |
| Current Ratio | 8.00 | 10.27 | 24.15 | 1.30 | n/a |
| Asset Turnover | 0.02 | n/a | n/a | n/a | n/a |
| Interest Coverage | -17.29 | -30.18 | -54.66 | -27.62 | -42.82 |
| Return on Equity (ROE) | -0.64 | -0.64 | -0.78 | 0.49 | n/a |
| Return on Assets (ROA) | -0.42 | -0.49 | -0.61 | -0.94 | n/a |
| Return on Capital (ROIC) | -0.53 | -0.52 | -0.23 | -3.37 | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 100.00% | n/a | n/a | n/a | n/a |
| Net Profit Margin | -2.20K% | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -2.57K% | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -2.50K% | n/a | n/a | n/a | n/a |
| FCF Margin | -2.34K% | n/a | n/a | n/a | n/a |
| EBITDA Margin | -2.42K% | n/a | n/a | n/a | n/a |